Funding for this research was provided by:
Novo Nordisk Fonden (NNF14CC0001)
Received: 1 August 2019
Accepted: 21 April 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: All data are observational, all subjects are anonymised and no ethical approval was requested.
: Not applicable.
: NKE, SBC, TSA, MJB and SLH are employees at Novo Nordisk. SBC, TSA, MJB and SLH are shareholders in Novo Nordisk A/S.RE and SB are affiliated with Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. In addition, SB is associated with Technical University of Denmark, Dept. of Bio and Health Informatics as professor (consultancy) and Copenhagen University Hospital, Rigshospitalet as Senior Medical Informatics Officer (consultancy). SB has stocks in: Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S. Further SB has compensated Managing Board Membership in Proscion A/S and Intomics A/S. SB declares that the financial interests listed have no impact on the submitted work.